AI identifies tumor aging patterns to predict immunotherapy response across multiple cancer types

AI Summary

POSTECH researchers developed an AI system that analyzes tumor aging patterns to predict which patients across multiple cancer types are likely to respond to immunotherapy. The approach aims to help clinicians identify likely treatment beneficiaries before therapy begins.

Even when given the same drug, some patients respond well while others show little or no response. This is particularly true of immunotherapy. A research team at POSTECH (Pohang University of Science and Technology) has developed an artificial intelligence (AI) technology that can predict, in advance, which patients are likely to benefit from treatment.